Silver Ruthenium Antimicrobial Composition for Herpes Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for herpes simplex virus infections, including antiviral creams and patches, only alleviate symptoms and do not effectively prevent the onset or shorten the duration of cold sore outbreaks, posing a significant burden for patients with frequent recurrences.
Innovation Solution
An antimicrobial composition comprising metallic silver and ruthenium, activated by ascorbic acid or its derivatives, is applied topically to treat and prevent herpes simplex virus infections by creating a microelectric field that generates reactive oxygen species, effectively killing microorganisms and preventing biofilm formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antiviral creams or patches are used, then symptoms are alleviated, but the duration of herpes outbreaks is not significantly shortened
Solution Approach 1:
The patent uses a composite material consisting of silver particles, ruthenium particles, and vitamin E suspended in a carrier substance. This combination of multiple components with different properties creates a synergistic effect that enhances antiviral activity and accelerates healing compared to conventional single-ingredient treatments.
Solution Approach 2:
The invention changes the chemical and physical parameters of the treatment by using metallic particles in the nanometer to micrometer size range, combined with vitamin E in specific concentrations (0.1-10% w/w). These parameter changes enable the composition to penetrate and inactivate the herpes virus more effectively, shortening outbreak duration to 2-4 days.
2Reliability
If antiviral medications are applied, then cell metabolism is inhibited, but complete suppression of herpes onset and prevention of blister formation is not achieved
Solution Approach 1:
The composition is designed to be applied at the very onset of herpes symptoms (tingling, skin tension, or swelling) before blisters form. The silver and ruthenium particles immediately inactivate the virus through membrane disruption and oxidative damage, preventing the progression to blister stage and achieving complete suppression when applied promptly.
3Reliability
If silver is used for antimicrobial treatment, then microorganisms are killed, but antibiotic-resistant bacteria may develop
Solution Approach 1:
The patent converts potentially harmful silver ions that could contribute to resistance into beneficial metallic particles that physically penetrate and mechanically disrupt microbial membranes. The combination with ruthenium particles and vitamin E creates a multi-mechanism approach that generates reactive oxygen species and causes direct physical damage, making it highly unlikely for microorganisms to develop resistance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antimicrobial composition significantly shortens the duration of herpes outbreaks by suppressing symptoms and preventing blister formation, offering a more effective alternative to existing treatments by completely resolving herpes symptoms within a day and reducing the overall healing time by several days.
Implementation Method 1
An antimicrobial composition comprising metallic silver and ruthenium, activated by ascorbic acid or its derivatives, is applied topically to treat and prevent herpes simplex virus infections by creating a microelectric field that generates reactive oxygen species
Implementation Method 2
The antimicrobial composition comprises metallic silver and metallic ruthenium and at least one vitamin or at least one derivative of a vitamin. In the present invention it is contemplated that the vitamin is ascorbic acid or a salt of ascorbic acid. Surprisingly, it turned out that a combination of the precious metals silver and ruthenium, activated by a vitamin, has a germ-killing effect
Data Source
Figure 1~2
Figure 3
Figure 4a~4c
AI summary
The invention relates to the use of an antimicrobial composition comprising metallic silver and metallic ruthenium, as well as at least one vitamin or at least one vitamin derivative, for the topical treatment or prevention of diseases of the skin, skin appendages, or mucous membranes caused by infection with at least one microorganism. The invention further relates to a dressing material or adhesive bandage comprising an antimicrobial composition comprising metallic silver and metallic ruthenium, as well as at least one vitamin or at least one vitamin derivative. The antimicrobial composition ("AgXX") exhibits broad-spectrum activity against bacteria (a: E. coli) and fungi (b: pathogenic yeast and c: Penicillium notatum). a) Escherichia coli (with the addition of silver ("Ag") as a control), b) Candida parapsilosis, c) Penicillium notatum;